Pharma Cos. Hit With $2M Judgment Over CBD Investor Fraud
By Mike Curley · May 7, 2026, 6:03 PM EDT
A California federal judge has issued final judgments against a pharmaceutical company, its CEO and an affiliate on claims from the U.S. Securities and Exchange Commission that they defrauded investors of...
To view the full article, register now.